Notably, the apoptotic capacity of tumor cells was significantly enhanced by silencing LOXL2 but not significantly decreased by overexpression of LOXL2, but this was considered to be related to the KYSE cell background apoptotic capacity threshold. This evidence concerns the gene LOXL2 and neoplasm.